WeTrials
Active, not recruiting

A Randomized, Controlled Trial to Assess the Clinical Utility of a Multi-cancer Early Detection (MCED) Test for Population Screening in the United Kingdom (UK) When Added to Standard of Care

What is this study?

This study is testing a new blood test called the Galleri test to see if it can help find many different types of cancer early. Finding cancer early is important because it makes the disease much easier to treat successfully.

Who can participate?

You may be able to join if you are between 50 and 77 years old and can give your own consent. People who have had cancer in the last three years or are currently being evaluated for cancer cannot join.

What will happen?

Participants will have their health followed for about three years to see how well the blood test works alongside standard NHS cancer screenings. You will help researchers learn if this new test can improve early cancer detection.

Where and when?

The study takes place in Macclesfield, United Kingdom. It is currently active but is no longer looking for new participants.

Key Points
  • 1Testing a new blood test to find multiple types of cancer early
  • 2Involves 140,000 participants followed over a three-year period
  • 3Study is currently active but not recruiting new participants in Macclesfield, UK

Related video

pharmaphorum: Prof. Peter Sasieni on the NHS-Galleri trial results at ASCO 2026 (June 2026)

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Cancer

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.